Print Page   |   Contact Us   |   Sign In   |   Join
ACRM Abstract Guidelines

Abstract Submission Guidelines

North American Society for Pediatric and Adolescent Gynecology

32nd Annual Clinical and Research Meeting

West Palm Beach Hilton
West Palm Beach, FL
April 12-14, 2018

 

The NASPAG Program Committee invites you to submit abstracts pertinent to the field of pediatric and adolescent gynecology for presentation at the 32nd Annual Clinical Research Meeting (ACRM). Abstracts describing original research or case reports/series will be considered. The timeline for abstract submissions is as follows:

 

 

 

Timeline

 

 

September 1, 2017

 

 

Abstract site open for submission

 

Deadline Extended

October 27, 2017

 

Final Day for Abstract Submission

Abstract site closes at 11:59pm Eastern Standard Time

(no technical support after 5:00 pm EST)

December 18, 2017

 

Notification of acceptance/rejection of abstracts

 

January 19, 2018

 

Author response (accept/decline requested)

 

 

 

Abstracts submitted may contain original work or work previously presented at a meeting of another national or international scientific organization.  Approval by your institution’s local Institutional Review Board (IRB) or equivalent is preferred. Abstracts must be submitted via the Elsevier website at http://ees.elsevier.com/naspag. Only abstracts submitted electronically will be accepted for review.

 

 

A. PREPARATION OF WRITTEN ABSTRACTS

General Formatting

  • Abstracts should be written in Times New Roman or Arial font, single-spaced, with no smaller than 11pt type, and 1-inch margins on all sides
  • The body of the abstract is limited to 2,750 characters which may include up to two tables or figures. Title, authors, and spaces are not included in the character count
  • Authors must submit two copies of the abstract
    • Non-Blinded copy with authors and institutions listed for publication purposes
    • Blinded copy without authors or institutions listed for review/scoring purposes
  • Standard abbreviations as listed in the American Medical Associations Stylebook on Medical Writing may be used
  • All other abbreviations should be clearly defined

 

 

Title/Authors

  • Title should appear in all capital letters
  • All authors with their degrees should be listed
  • Titles, positions or appointments are not to be included
  • The presenting author should be the first author on the abstract, and their name should be underlined
  • The *senior author should be designated by an *asterisk
  • A conflict of interest form from each author must be submitted at the time of abstract submission
  • Institution where the research was conducted, followed by city and state (and country, if not U.S.)

Note: author and institution information should not appear in the body of the text in order to ensure blinded review/scoring

 

 

Content
           

  • Case Report/Series

The abstract should be organized into three sections, each labeled in all capital letters and bolded

    • BACKGROUND – focused statement of 2-3 sentences indicating topic background, importance and learning objective
    • CASE - description of up to ten cases of a condition that is unusual or instructive
    • COMMENTS - statement of importance/implications of case, related to identified learning objective

  • Original Research

The abstract should be organized into four sections each labeled in capital letters and bolded

    • BACKGROUND – focused statement of 2-3 sentences indicating topic background, importance and the study objective and/or hypothesis
    • METHODS – subjects, recruitment, procedures/interventions, predictors and outcome measures, statistical methods, IRB approval
    • RESULTS – specific findings of the study, with statistical significance indicated where appropriate
    • CONCLUSIONS – statement of importance/implications of findings, drawn from data presented and related to the stated objective of the study

 

B. POSTER OR ORAL PRESENTATION

All abstracts will be considered for oral presentation unless the author designates “Poster Only” in box provided. Abstracts not selected for oral presentation will be considered for poster presentation.

  • Oral presentations will be 10 minutes in length followed by 5 minutes of discussion.
  • Posters will be available during poster sessions and will displayed for an extended period of time before each session to allow for meeting attendees to fully peruse the research.  Authors must be available to discuss their work and answer questions.

 

Detailed instructions for preparation of oral or poster presentations will be included with abstract acceptance notification.

 

 

C. IDENTIFICATION/COMMUNICATION

On the Author Information page of the submission website, the presenting author (listed first on the abstract) MUST include his/her:

  • name
  • email address
  • mailing address
  • telephone number
  • fax number

This information does not need to be included on the uploaded abstract documents.

 

Notification of acceptance/rejection will be emailed to the presenting/first author only, by December 18, 2017. If you do not receive notification of the status of your abstract by this date, email naspagmtgs@talley.com.  Author responses either accepting or declining the offer to present are due by January 19, 2018.

 

All decisions by the Abstract Committee are final.  Abstracts without clear relevance to pediatric and adolescent gynecology will not be accepted.  Additionally, abstracts of work previously published or under review as a manuscript in any journal will not be accepted.  Reviewer scores are not provided to the authors.

 

D. ABSTRACTS PREVIOUSLY SUBMITTED FOR PRESENTATION AT OTHER MEETINGS

If the abstract content has been previously submitted for presentation at a meeting of another national or international scientific organization, this must be disclosed in the appropriate box on the NASPAG abstract submission site, along with the outcome of the submission (accepted-oral, accepted-poster, rejected, or decision pending), and the name and date of the meeting.

 

Previously submitted abstracts may not be published in JPAG depending on copyright permissions.  For abstracts accepted for presentation at the NASPAG ACRM, if previously submitted to another meeting:

  • If abstract was Rejected from other meeting, no additional permissions/information needed.
  • If abstract was Accepted and will be presented at the other meeting prior to the NASPAG ACRM, the author is responsible for obtaining permission for abstract publication in JPAG.  Without such permission, the abstract may not be published in JPAG.  Permission must be submitted during the abstract submission window.
  • If abstract was Accepted or Pending presentation at another meeting which will take place after the NASPAG ACRM, the abstract will be published in JPAG.  The author is responsible for verifying that presentation at NASPAG and publication in JPAG is acceptable for the other meeting.

These restrictions and author responsibilities will be clearly outlined in decision letters for abstracts accepted for presentation at the NASPAG ACRM.

 

E. NASPAG AWARDS

The Abstract Committee will select the recipients of the following awards for Original Research presented at the ACRM:

  • Huffman-Capraro Award for the best oral research presentation by a trainee (Fellow, Resident or Student).
    • To qualify, the student/resident/fellow must:
      • be a student who registered in an accredited medical or graduate school or doctoral level graduate who is registered in an accredited residency or fellowship program.  Eligibility is maintained for one (1) additional year following the completion of the training program,
      • be the first author and presenter on the abstract submitted for presentation,
      • participate in the study design and contribute significantly to the formulation of the hypothesis, collection of data and data analysis.
      • designate their abstract as being eligible for the award at the time of abstract submission
    • Priority will be given for experimental study designs and to prospective studies.
    • Authors whose abstracts are chosen for an oral presentation must submit a letter from their program director or department head, attesting to the degree of involvement by the student/resident/fellow in the research and in the preparation of the abstract by January 19, 2018.
    • The author is expected to prepare a manuscript from this study which will be given priority consideration for publication in the official journal of NASPAG - The Journal of Pediatric and Adolescent Gynecology..
    • An award of $1000 and a certificate will be presented to the award-winning presentation.
    • If you ask to be eligible for the Huffman-Capraro Award you will not be eligible for the Evelyn Green Laufer Award

 

  • Evelyn Green Laufer Award for the best oral presentation, as judged by the Abstract Committee, with cash prize.

 

  • Sally E. Perlman Award for the best poster presentation, as judged by the Abstract Committee, with cash prize.

 

All awards will be announced and the recipients recognized on the last day of the meeting.

 

All questions about abstract submission should be directed to naspagmtgs@talley.com. Please note that no abstracts submitted after the OCTOBER 20, 2017 deadline will be accepted.  The deadline WILL NOT BE EXTENDED.

 

Association Management Software Powered by YourMembership  ::  Legal